Genetic association of interleukin-1β (- 511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians

Clinica Chimica Acta

Volumn 377, Issue 1-2, 2007, Pages 163-169

  Achyut, B R ^a   Srivastava, Akanksha ^a   Bhattacharya, Sandeep ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Diabetic complications; Gene polymorphism; Genetic association; Proinflammatory cytokines; Type 2 diabetes

Indexed keywords

CYTOSINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; TYROSINE;

ADULT; ALLELE; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GEL ELECTROPHORESIS; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; INTERLEUKIN 1BETA GENE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; VARIABLE NUMBER OF TANDEM REPEAT;

CYTIDINE; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; INDIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; THYMIDINE;

EID: 33845416114     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.09.012     Document Type: Article

References (37)

1. Ritz E., Hasslacher C., and Tschope W. Diabetic nephropathy - are there differences between type I and type II?. Miner Electrolyte Metab 16 (1990) 69-72
2. Hendriksen P.H., Oey P.L., Wieneke G.H., Bravenboer B., and Banga J.D. Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 35 (1992) 690-695
3. McCarthy M.I. Progress in defining the molecular basis of type 2 diabetes through susceptibility gene identification (Suppl 1). Hum Mol Genet 13 (2004) R33-R41
4. Samanta A, Burden AC, Fent B. Comparative prevalence of insulin dependant diabetes mellitus in Asian and white Caucasian adults. Diabetes Res Clin Pract 198;74:1-6.
5. Lavery L.A., Ashry H.R., van Houtum W., Pugh J.A., Harksless L.B., and Basu S. Variation in the incidence and proportion of diabetes related amputations in minorites. Diabetes Care 19 (1996) 48-52
6. Seaquist E.R., Goetz F.C., Rich S., and Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320 (1989) 1161-1165
7. Joachim S., Anja K., and Matthias M. Inflammatory cytokines and the risk to develop type 2 diabetes. Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52 (2003) 812-817
8. Pickup J.C., and Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 41 (1998) 1241-1248
9. Mansfield J.C., Holden H., and Tarlow J.K. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106 (1994) 637-642
10. Cork M.J., Tarlow J.K., and Blakemore A.I.F. Genetics of IL-1 receptor antagonist in inflammatory skin diseases (abstract). J Invest Dermatol 100 (1993) 522
11. Nicklin M.J., Weith A., and Duff G.W. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 b, and interleukin-1 receptor antagonist genes. Genomics 19 (1994) 382-384
12. Dinarello C.A. The role of the interleukin-l-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343 (1994) 732-734
13. Ole P.K., Flemming P., Jesper J., Regine B., and Charles A.D. Linkage disequilibrium testing of four interleukin-1 gene-cluster polymorphisms in Danish multiplex families with insulin-dependent diabetes mellitus. Cytokine 12 (2000) 171-175
14. Furuta T., El-Omar E.M., and Xiao F. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123 (2002) 92-105
15. Tarlow J.K., Blakemore A.I., Lennard A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91 (1993) 403-404
16. Latkovskis G., Licis N., and Kalnins U. C-reactive protein concentrations and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 31 5 (2004) 207-213
17. Lee S.H., Ihm C.G., and Sohn S.D. Polymorphisms in interleukin-1 beta and Interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am J Nephrol 24 (2004) 410-414
18. Blakemore A.I., Tarlow J.K., Cork M.J., et al. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37 (1994) 1380-1385
19. Dixit M., Bhattacharya S., and Mittal B. Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study. BMC Endocr Disord 1 (2005) 5-7
20. Miller S., and Dykes D. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
21. Rad R., Prinz C., Neu B., et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 188 (2003) 272-281
22. Schneider S., Roessli D., and Excoffier L. Arlequin ver. 2.00. A software for population genetics data analysis (2000), Genetics and Biometry Laboratory, University of Geneva, Switzerland
23. Sham P.C., and Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59 (1995) 97-105
24. Tsiavou A., Hatziagelaki E., Chaidaroglou A., et al. TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol 24 (2004) 591-599
25. Danielsson P., Truedsson L., Eriksson K.F., and Norgren L. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus. Vasc Med 10 (2005) 191-198
26. Zeggini E., Groves C.J., Parkinson J.R., et al. Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes. Diabetologia 48 (2005) 2013-2017
27. *2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 47 (1998) 195-198
28. Hwang I.R., Kodama T., Kikuchi S., et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1 beta production in H. pylori infection. Gastroenterology 123 (2002) 1793-1803
29. Danis V.A., Millington M., Hyland V.J., et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist gene polymorphism. Clin Exp Immunol 99 (1995) 303-310
30. Pastor I.J., Laso F.J., Romero A., and Gonzalez-Sarmiento R. Interleukin-1 gene cluster polymorphisms and alcoholism in Spanish men. Alcohol Alcohol 40 (2005) 181-186
31. Jari K., Tarja L., Helena K., et al. IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion. J Reprod Immunol 58 (2003) 61-67
32. Watanabe E., Hirasawa H., Oda S., et al. Extremely high interleukin-6 blood concentrations and outcome in the critically ill are associated with tumor necrosis factor-alfa and interleukin-1-related gene polymorphisms. Crit Care Med 3 (2005) 89-97
33. Bastard J.P., Jardel C., Bruckert E., et al. Elevated concentrations of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85 (2000) 3338-3342
34. Tam F.W.K., Smith J., Cashman S., et al. Coordinated expression of glomerular interleukin-1 beta and its receptor antagonist (IL-1ra) mRNA and infiltration of leukocytes during induction of nephrotoxic nephritis in rat. J Am Soc Nephrol 3 (1992) 617 [abstract]
35. Loughrey B.V., Maxwell A.P., and Fogarty D.G. An interleukin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 10 (1998) 984-988
36. Lind H., Zienolddiny S., Ryberg D., Skaug V., Phillips D.H., and Haugen A. Interleukin-1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene. Lung Cancer 50 (2005) 285-290
37. Vamvakopoulos J.E., Taylor C.J., Green C., et al. Interleukin-1 and chronic rejection: possible genetic links in human heart allografts. Am J Transplant 2 (2002) 76-83